Lv11
88 积分 2024-10-11 加入
Tinengotinib for adults with advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 trial
11小时前
已完结
Are Biopsy Specimens Effective for Evaluating HER2 Expression in Extrahepatic Bile Duct and Gallbladder Cancer?
11小时前
已完结
Age-standardized mortality-to-incidence ratio for gallbladder cancer in the world
11小时前
已关闭
Adjuvant camrelizumab combined with capecitabine in patients with intrahepatic cholangiocarcinoma after surgical resection in China (ACC): a single-arm, single-centre, open-label, phase 2 trial
19天前
已完结
Vessels encapsulating tumor clusters is associated with impaired efficacy of adjuvant immunotherapy in resected hepatocellular carcinoma
25天前
已完结
Sitravatinib Targets TYRO3 to Augment the Antitumor Immune Response of PD-1 Blockade in Hepatocellular Carcinoma
25天前
已完结
Idarubicin versus Epirubicin in Transarterial Chemoembolization for Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma: An Open-label, Randomized, Phase IV Trial
25天前
已完结
Online risk scores for pre- and postoperative prediction of early recurrence in hepatocellular carcinoma patients undergoing conversion liver resection after tyrosine kinase inhibitors and immune checkpoint inhibitors therapy
25天前
已完结
Second-Line Treatment in cholangiocarcinoma - Current State of the Art and Future Perspectives
2个月前
已完结
Demographic and Regional Trends in Mortality Related to Cholangiocarcinoma in the United States
2个月前
已关闭
皖公网安备34019202002308
